The proteasome inhibitor bortezomib (Velcade) sensitizes some human tumor cells to Apo2L/TRAIL-mediated apoptosis

Alan D. Brooks, Teresa Ramirez, Uhi Toh, Jennifer Onksen, Peter J. Elliott, William J Murphy, Thomas J. Sayers

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint Dive into the research topics of 'The proteasome inhibitor bortezomib (Velcade) sensitizes some human tumor cells to Apo2L/TRAIL-mediated apoptosis'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences

Arts & Humanities